Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “AIDS Vaccines”

679 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 679 results

Post-approval studies (Phase 4)UnknownNCT05075044
What this trial is testing

Immunogenicity and Safety of an Inactivated COVID-19 Vaccine in People Aged ≥18 Years With HIV Infected

Who this might be right for
HIV InfectionsCOVID-19
China National Biotec Group Company Limited 400
Testing effectiveness (Phase 2)Study completedNCT00880698
What this trial is testing

Safety and Immune Response of a Rotavirus Vaccine in HIV-infected and Uninfected Children Born to HIV-infected Mothers

Who this might be right for
HIV InfectionRotavirus Infection
National Institute of Allergy and Infectious Diseases (NIAID) 202
Not applicableUnknownNCT05578144
What this trial is testing

Using "SDM With PDAs" to Help Infant Family to Decide the Third Primary Dosing Pneumococcal Conjugate Vaccine

Who this might be right for
Infants' Family Decide Baby's Vaccine
Taipei Medical University Shuang Ho Hospital 180
Early research (Phase 1)Study completedNCT00252148
What this trial is testing

Safety and Immunogenicity of a Modified Vaccinia Ankara (MVA) HIV Vaccine in HIV Uninfected Adults

Who this might be right for
HIV Infection
International AIDS Vaccine Initiative 48
Testing effectiveness (Phase 2)Study completedNCT00000815
What this trial is testing

A Phase II, Comparative Study of Seroconversion of Single-Dose and Two-Dose Measles Vaccination in HIV-Infected and HIV-Uninfected Children: A Multicenter Trial of the Pediatric AIDS Clinical Trials Group

Who this might be right for
HIV InfectionsMeasles
National Institute of Allergy and Infectious Diseases (NIAID) 270
Early research (Phase 1)Study completedNCT00001055
What this trial is testing

A Phase I Safety and Immunogenicity Trial of Live Recombinant Canarypox ALVAC-HIV (vCP205) in HIV-1 Uninfected Adult Volunteers

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 76
Post-approval studies (Phase 4)Study completedNCT01538940
What this trial is testing

Immunogenicity of Influenza Vaccines in HIV-infected Persons in Thailand

Who this might be right for
Influenza
Centers for Disease Control and Prevention 415
Not applicableStudy completedNCT06915779
What this trial is testing

Long Term Follow-up of HPV Vaccine in HIV (CTN 236)

Who this might be right for
Cervical CancerHuman Papillomavirus InfectionHuman Immunodeficiency Virus+2 more
University of British Columbia 241
Large-scale testing (Phase 3)Study completedNCT01032408
What this trial is testing

Immunogenicity, Safety, and Tolerability of MF59-Adjuvanted Versus Non-Adjuvanted Influenza Vaccines in Patients With HIV-1 Infection

Who this might be right for
H1N1 Influenza VirusHuman Immunodeficiency Virus Type 1 (HIV-1) Infection
Chiltern Pesquisa Clinica Ltda 154
Post-approval studies (Phase 4)Active Not RecruitingNCT05575830
What this trial is testing

Immune Response of Shingrix Vaccine in People Living With HIV (> 50 y.o.) Compared to Age-matched Controls

Who this might be right for
RZV Vaccine (Shingrix ®)
Calmy Alexandra 225
Early research (Phase 1)Study completedNCT00000774
What this trial is testing

A Phase I Study to Evaluate the Safety and Immunogenicity of Recombinant HIV-1 Envelope Antigen in Children Born to HIV-Infected Mothers

Who this might be right for
HIV InfectionsHIV Seronegativity
National Institute of Allergy and Infectious Diseases (NIAID) 156
Early research (Phase 1)Study completedNCT00321061
What this trial is testing

Phase I Study of Vaccination Schedule of Experimental HIV Vaccines

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 60
Early research (Phase 1)Study completedNCT04586673
What this trial is testing

Assess Safety and Immunogenicity of Conserved Mosaic HIV-1 Vaccines

Who this might be right for
HIV
University of Oxford 13
Not applicableEnrolling By InvitationNCT06144229
What this trial is testing

Real-world Effectiveness of HPV Vaccine in Women Living With HIV and Its Impact on Cervical Cancer Screening Accuracies

Who this might be right for
HivHpv
University of California, Los Angeles 810
Post-approval studies (Phase 4)Study completedNCT00142753
What this trial is testing

Immunologic Memory (Supp. of ATN 024)

Who this might be right for
HIV Infections
University of North Carolina, Chapel Hill 95
Early research (Phase 1)Study completedNCT00107549
What this trial is testing

Safety of Recombinant HIV Vaccines in HIV Infected Young Adults on Stable Therapy

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 20
Early research (Phase 1)Study completedNCT00528489
What this trial is testing

Safety and Effectiveness of PENNVAX-B Vaccine Alone, With Il-12, or IL-15 in Healthy Adults

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 120
Testing effectiveness (Phase 2)Study completedNCT01697007
What this trial is testing

A Phase II Trial to Assess the Safety and Immunogenicity of DNA Priming Administered by the ID Zetajet® With or Without ID Derma Vax™ Electroporation Followed by IM MVA Boosting in Healthy Volunteers in Tanzania and Mozambique

Who this might be right for
VaccinesHIVSafety+1 more
Muhimbili University of Health and Allied Sciences 198
Early research (Phase 1)Study completedNCT00195234
What this trial is testing

Study Evaluating Vaccine in Adults With HIV

Who this might be right for
HIV Infections
Wyeth is now a wholly owned subsidiary of Pfizer 60
Early research (Phase 1)Study completedNCT01266616
What this trial is testing

Safety of and Immune Response to an Investigational HIV-1 Vaccine With or Without Interleukin-12 (IL-12) in HIV-1 Infected Adults

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 62
Load More Results